Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo.
about
Vitiligo: interplay between oxidative stress and immune systemHighlights in pathogenesis of vitiligoMeta-Analysis of the Association between Vitiligo and Human Leukocyte Antigen-AIdentification of peptides specific for antibodies in vitiligo using a phage library.Assessment methods for the evaluation of vitiligo.Autoimmune melanocyte destruction in vitiligo.Tumor necrosis factor B (TNFB) genetic variants and its increased expression are associated with vitiligo susceptibilityPresence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance.Mammalian tyrosinase-related protein-1 is recognized by autoantibodies from vitiliginous Smyth chickens. An avian model for human vitiligoAvian models with spontaneous autoimmune diseases.Autoantibodies as diagnostic and predictive markers of vitiligo.When are laboratory tests indicated in patients with vitiligo?Therapeutic implications of autoimmune vitiligo T cells.Vitiligo: auto-immunity and immune responses.The role of IL-17 in vitiligo: A reviewVitiligo, reactive oxygen species and T-cells.The pathogenesis of vitiligo.Stability in Vitiligo: Is there a Perfect Way to Predict it?Vitiligo: what's new in the psycho-neuro-endocrine-immune connection and related treatments.Oxidative stress and immune system in vitiligo and thyroid diseases.Vitiligo: An Update on Pathophysiology and Treatment Options.Whole Transcriptome Analysis (RNA Sequencing) of Peripheral Blood Mononuclear Cells of Vitiligo Patients.Interactome analysis of gene expression profile reveals potential novel key transcriptional regulators of skin pathology in vitiligo.The role of systemic steroids and phototherapy in the treatment of stable vitiligo: a randomized controlled trial.Narrow-band UVB irradiation stimulates the migration and functional development of vitiligo-IgG antibodies-treated pigment cells.Function-blocking autoantibodies to the melanin-concentrating hormone receptor in vitiligo patients.Melanocyte destruction and repopulation in vitiligo.Review of the etiopathomechanism of vitiligo: a convergence theory.Vitiligo: where do we stand?A Case of Vitiligo after Kawasaki's DiseaseIFN-γ, IL-21, and IL-10 co-expression in evolving autoimmune vitiligo lesions of Smyth line chickens.The melanocytorrhagic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis.Autoantibodies in vitiligo patients are not directed to the melanocyte differentiation antigen MelanA/MART1.Genes of the LMP/TAP cluster are associated with the human autoimmune disease vitiligo.Elevated serum antimelanocyte antibody level in cerebriform intradermal nevus with vitiligo.Vitiligo and Autoimmune Thyroid Disorders.Vitiligo patients from India (Mumbai) show differences in clinical, demographic and autoantibody profiles compared to patients in western countries.An objective assessment of melanin in vitiligo skin treated with Balneo PUVA therapy.Evaluation of serum immunoglobulins concentrations and distributions in vitiligo patients.Further evidence for involvement of both cell mediated and humoral immunity in generalized vitiligo.
P2860
Q26824504-01004DAE-EB3B-4ADB-8CE0-F02603B72700Q26851509-3302460E-5C12-429E-B0F4-433804F15CA3Q28076708-3FE300E3-F44E-43BF-AF74-D75263ED6B3CQ33224361-AD714B2A-F2C5-4DF8-B22E-099E0D0F7477Q34195120-ACE8320B-DD0A-44AF-974B-B56F70EE4626Q34335855-3FC5CBAF-EE44-4A17-B577-B04363C75731Q35060678-BC3E2A96-BDA1-4553-A49B-C704F869BB98Q35773559-C583C391-A069-4F9E-8CBF-79DABC884D4DQ35798261-B7D5E128-E9AC-4838-AB21-52A5F849BB03Q35799365-D3619BE9-5397-4DF7-9BDC-88ACC7B79EB2Q35934690-E3FCC1B3-C84E-408B-8527-83CBF4CDC177Q36130025-3EF8A998-07E6-4A4C-8CC1-D289D1AF097CQ36292745-F733BFCD-AB92-4F06-A8AE-70B01349ACBCQ36478782-84DEC916-A6CD-4400-8BA0-49220DDB6503Q36625953-68B247E3-37E0-4B7F-B4D7-14495E6E6B7CQ37801388-879B5666-9C55-407E-8543-A5A18DEA6AB7Q38106804-FF284A3A-608D-4893-95DC-8C07B142DA76Q38136173-0395F2D6-BF3D-4C26-A462-D1159ADF5C7BQ38233632-9898BFF5-B28C-4AAA-BE28-F4602014386BQ38403600-DFA4965F-49A9-4516-BF8E-F27BED4D925EQ38675361-3901B736-C78C-4F1C-AFF4-BC3F40E6DA0BQ38700035-F5CB3684-BAD8-4637-BF5F-BB8BB7EAF5C6Q38943432-03D915A1-0359-42D2-A413-6632D9482641Q38985264-EB5124CF-81A4-4359-90BB-292F9FC4ECB3Q39547510-B52B5ABD-158D-436E-AC1C-807A761A7353Q40282263-720012F0-E35B-46F8-91A8-E32966D672DAQ40591940-93738240-A94F-4F66-A9CF-5B009236BDA5Q40742658-1555B6F7-C671-42A1-80FB-7AF338F3CB43Q40820967-DBE6D10A-6AC3-45EE-9F29-19349C2CD62FQ40971128-F07E9422-46C9-4BF4-BF58-32C55E6D2D62Q41080382-4A5A64EE-87BB-4CF6-A1F1-E80F395BE7FEQ42518695-E58F2505-B1F6-4597-B261-ED790B67FABFQ44116002-CDBCFEE5-BDE9-494A-BFBB-1FCE52BD35EBQ44613323-54CEF4E0-FF11-4EC4-969C-4456DF9FD94DQ45113275-F76C9F3C-3868-474D-9E45-7B0A882608DFQ46256690-E664FC4E-D675-4282-9894-9C4267F98554Q46953146-94B1D213-73DA-440B-BF73-97375B4444B2Q50799807-F1B9C887-E838-4AA3-B393-994CA1E29E3FQ50876213-B49CE9CC-FBBB-411C-A9AA-2A2CF465A80AQ53018606-A816E8DA-270E-4D06-BFE2-78E4AFB10AA6
P2860
Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Relation between the incidence ...... disease activity in vitiligo.
@en
type
label
Relation between the incidence ...... disease activity in vitiligo.
@en
prefLabel
Relation between the incidence ...... disease activity in vitiligo.
@en
P2093
P1476
Relation between the incidence ...... disease activity in vitiligo.
@en
P2093
P2888
P304
P356
10.1111/1523-1747.EP12492607
P407
P577
1991-12-01T00:00:00Z
P5875
P6179
1036901724